• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 E4 引起的胆固醇失调及其在阿尔茨海默病发病机制中的特定脑细胞类型影响。

ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease.

机构信息

Department of Brain and Cognitive Sciences, Daegu Gyeongbuk Institute of Science & Technology (DGIST), Daegu 42988, Korea.

出版信息

Mol Cells. 2019 Nov 30;42(11):739-746. doi: 10.14348/molcells.2019.0200.

DOI:10.14348/molcells.2019.0200
PMID:31711277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6883979/
Abstract

Significant knowledge about the pathophysiology of Alzheimer's disease (AD) has been gained in the last century; however, the understanding of its causes of onset remains limited. Late-onset AD is observed in about 95% of patients, and -encoding apolipoprotein E4 (ApoE4) is strongly associated with these cases. As an apolipoprotein, the function of ApoE in brain cholesterol transport has been extensively studied and widely appreciated. Development of new technologies such as human-induced pluripotent stem cells (hiPSCs) and CRISPR-Cas9 genome editing tools have enabled us to develop human brain model systems and readily manipulate genomic information. In the context of these advances, recent studies provide strong evidence that abnormal cholesterol metabolism by ApoE4 could be linked to AD-associated pathology. In this review, we discuss novel discoveries in brain cholesterol dysregulation by ApoE4. We further elaborate cell type-specific roles in cholesterol regulation of four major brain cell types, neurons, astrocytes, microglia, and oligodendrocytes, and how its dysregulation can be linked to AD pathology.

摘要

在上个世纪,人们对阿尔茨海默病(AD)的病理生理学有了重要的认识;然而,其发病原因仍知之甚少。约 95%的患者为迟发性 AD,载脂蛋白 E4(ApoE4)的编码与这些病例密切相关。作为一种载脂蛋白,ApoE 在大脑胆固醇转运中的功能已被广泛研究和充分认识。人类诱导多能干细胞(hiPSCs)和 CRISPR-Cas9 基因组编辑工具等新技术的发展使我们能够开发人类大脑模型系统,并轻松操纵基因组信息。在这些进展的背景下,最近的研究提供了强有力的证据,表明 ApoE4 异常的胆固醇代谢可能与 AD 相关的病理学有关。在这篇综述中,我们讨论了 ApoE4 导致大脑胆固醇失调的新发现。我们进一步阐述了四大主要脑细胞类型(神经元、星形胶质细胞、小胶质细胞和少突胶质细胞)中胆固醇调节的细胞类型特异性作用,以及其失调如何与 AD 病理学相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822d/6883979/719de17c5010/molce-42-739f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822d/6883979/3bb9750608a7/molce-42-739f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822d/6883979/719de17c5010/molce-42-739f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822d/6883979/3bb9750608a7/molce-42-739f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822d/6883979/719de17c5010/molce-42-739f2.jpg

相似文献

1
ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease.载脂蛋白 E4 引起的胆固醇失调及其在阿尔茨海默病发病机制中的特定脑细胞类型影响。
Mol Cells. 2019 Nov 30;42(11):739-746. doi: 10.14348/molcells.2019.0200.
2
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.载脂蛋白 E4 导致与人类 iPSC 衍生脑细胞类型的阿尔茨海默病表型相关的广泛分子和细胞改变。
Neuron. 2018 Jun 27;98(6):1141-1154.e7. doi: 10.1016/j.neuron.2018.05.008. Epub 2018 May 31.
3
APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation.载脂蛋白 E4 基因(APOE4)人类星形胶质细胞过度供应胆固醇,促进神经元脂筏扩张和 Aβ 生成。
Stem Cell Reports. 2021 Sep 14;16(9):2128-2137. doi: 10.1016/j.stemcr.2021.07.017. Epub 2021 Aug 26.
4
Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.载脂蛋白E2(apoE2)和载脂蛋白E4的病毒介导脑表达对apoE4靶向替代小鼠中apoE脂化和Aβ代谢的相反作用。
Mol Neurodegener. 2015 Mar 5;10:6. doi: 10.1186/s13024-015-0001-3.
5
Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.载脂蛋白 E4 在阿尔茨海默病发病机制中的作用及潜在治疗方法。
Cell Mol Neurobiol. 2023 Oct;43(7):3115-3136. doi: 10.1007/s10571-023-01365-1. Epub 2023 May 25.
6
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.胆固醇和基质体途径在星形胶质细胞和小胶质细胞中失调。
Cell. 2022 Jun 23;185(13):2213-2233.e25. doi: 10.1016/j.cell.2022.05.017.
7
APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes.载脂蛋白 E4 通过调控少突胶质细胞胆固醇影响髓鞘形成。
Nature. 2022 Nov;611(7937):769-779. doi: 10.1038/s41586-022-05439-w. Epub 2022 Nov 16.
8
Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.载脂蛋白 E4(ApoE4)在阿尔茨海默病发病机制中的作用:来自 ApoE 小鼠模型的启示。
Biochem Soc Trans. 2011 Aug;39(4):924-32. doi: 10.1042/BST0390924.
9
Cellular cholesterol homeostasis and Alzheimer's disease.细胞胆固醇稳态与阿尔茨海默病。
J Lipid Res. 2017 Dec;58(12):2239-2254. doi: 10.1194/jlr.R075630. Epub 2017 Mar 15.
10
Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.胶质细胞成熟因子与载脂蛋白 E4 在阿尔茨海默病脑中的共表达。
J Alzheimers Dis. 2018;61(2):553-560. doi: 10.3233/JAD-170777.

引用本文的文献

1
Insights into targeted ferroptosis in mechanisms, biology, and role of Alzheimer's disease: an update.阿尔茨海默病中靶向铁死亡的机制、生物学及作用的研究进展:最新综述
Front Aging Neurosci. 2025 Jul 21;17:1587986. doi: 10.3389/fnagi.2025.1587986. eCollection 2025.
2
Identification of and NLRP3 inflammasome activation in Alzheimer's disease retina.阿尔茨海默病视网膜中NLRP3炎性小体的鉴定及激活
Res Sq. 2025 Jun 26:rs.3.rs-6658954. doi: 10.21203/rs.3.rs-6658954/v1.
3
Identification of and NLRP3 inflammasome activation in Alzheimer's disease retina.

本文引用的文献

1
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.胆固醇和基质体途径在星形胶质细胞和小胶质细胞中失调。
Cell. 2022 Jun 23;185(13):2213-2233.e25. doi: 10.1016/j.cell.2022.05.017.
2
A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.代谢重编程的崩溃导致阿尔茨海默病中小胶质细胞功能障碍。
Cell Metab. 2019 Sep 3;30(3):493-507.e6. doi: 10.1016/j.cmet.2019.06.005. Epub 2019 Jun 27.
3
Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.
阿尔茨海默病视网膜中NLRP3炎性小体的鉴定及激活
bioRxiv. 2025 Jun 25:2025.06.19.660619. doi: 10.1101/2025.06.19.660619.
4
GPR101 loss promotes insulin resistance and diet-induced obesity risk.GPR101缺失会增加胰岛素抵抗和饮食诱导的肥胖风险。
Neurosci Appl. 2023 Apr 19;2:101126. doi: 10.1016/j.nsa.2023.101126. eCollection 2023.
5
Cholesterol-mediated Lysosomal Dysfunction in Astrocytes Promotes α-Synuclein Pathology in Human Brain Tissue.胆固醇介导的星形胶质细胞溶酶体功能障碍促进人脑组织中的α-突触核蛋白病理改变。
bioRxiv. 2025 Feb 14:2025.02.09.637107. doi: 10.1101/2025.02.09.637107.
6
Assessing the causal role of lipid metabolites in Alzheimer's disease: A mendelian randomization study.评估脂质代谢产物在阿尔茨海默病中的因果作用:一项孟德尔随机化研究。
J Prev Alzheimers Dis. 2025 Apr;12(4):100067. doi: 10.1016/j.tjpad.2025.100067. Epub 2025 Jan 23.
7
Modulatory Effect of Blood LDL Cholesterol on the Association between Cerebral Aβ and Tau Deposition in Older Adults.血液 LDL 胆固醇对老年人脑 Aβ 和 Tau 沉积相关性的调节作用。
J Prev Alzheimers Dis. 2024;11(6):1767-1774. doi: 10.14283/jpad.2024.131.
8
AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer's disease mice.新型APOE2-克赖斯特彻奇变体的腺相关病毒rh.10载体递送可抑制阿尔茨海默病小鼠的淀粉样蛋白和tau病理变化。
Mol Ther. 2024 Dec 4;32(12):4303-4318. doi: 10.1016/j.ymthe.2024.11.003. Epub 2024 Nov 6.
9
Contrasting association pattern of plasma low-density lipoprotein with white matter integrity in APOE4 carriers versus non-carriers.载脂蛋白 E4 携带者与非携带者的血浆低密度脂蛋白与脑白质完整性的对比关联模式。
Neurobiol Aging. 2024 Nov;143:41-52. doi: 10.1016/j.neurobiolaging.2024.08.005. Epub 2024 Aug 22.
10
Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage.胆固醇代谢:脑出血中的生理与病理方面
Neural Regen Res. 2025 Apr 1;20(4):1015-1030. doi: 10.4103/NRR.NRR-D-23-01462. Epub 2024 Apr 3.
早发性阿尔茨海默病与低密度脂蛋白胆固醇水平升高及 APOB 罕见遗传编码变异的关联。
JAMA Neurol. 2019 Jul 1;76(7):809-817. doi: 10.1001/jamaneurol.2019.0648.
4
Single-cell transcriptomic analysis of Alzheimer's disease.阿尔茨海默病的单细胞转录组分析。
Nature. 2019 Jun;570(7761):332-337. doi: 10.1038/s41586-019-1195-2. Epub 2019 May 1.
5
Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis.少突胶质细胞在髓鞘修复过程中的基因表达揭示胆固醇稳态是多发性硬化症的治疗靶点。
Proc Natl Acad Sci U S A. 2019 May 14;116(20):10130-10139. doi: 10.1073/pnas.1821306116. Epub 2019 Apr 30.
6
Age-associated cholesterol reduction triggers brain insulin resistance by facilitating ligand-independent receptor activation and pathway desensitization.与年龄相关的胆固醇降低通过促进非配体依赖性受体激活和信号通路脱敏引发脑胰岛素抵抗。
Aging Cell. 2019 Jun;18(3):e12932. doi: 10.1111/acel.12932. Epub 2019 Mar 18.
7
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.基于诊断的阿尔茨海默病的全基因组关联荟萃分析鉴定出新的风险位点,并提示 Aβ、tau、免疫和脂类代谢过程的作用。
Nat Genet. 2019 Mar;51(3):414-430. doi: 10.1038/s41588-019-0358-2. Epub 2019 Feb 28.
8
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.TREM2 功能丧失会增加淀粉样蛋白的形成,但会减少斑块相关的载脂蛋白 E。
Nat Neurosci. 2019 Feb;22(2):191-204. doi: 10.1038/s41593-018-0296-9. Epub 2019 Jan 7.
9
Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention.人载脂蛋白 E 异构体差异调节脑葡萄糖和酮体代谢:对阿尔茨海默病风险降低和早期干预的影响。
J Neurosci. 2018 Jul 25;38(30):6665-6681. doi: 10.1523/JNEUROSCI.2262-17.2018. Epub 2018 Jul 2.
10
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.载脂蛋白 E4 导致与人类 iPSC 衍生脑细胞类型的阿尔茨海默病表型相关的广泛分子和细胞改变。
Neuron. 2018 Jun 27;98(6):1141-1154.e7. doi: 10.1016/j.neuron.2018.05.008. Epub 2018 May 31.